Esketamine as a treatment for paediatric depression: questions of safety and efficacy - Zimmermann KS, Richardson R, Baker KD.

Adolescent-onset depression and anxiety represent a substantial, and growing, health-care burden. Unfortunately, traditional treatments for depression and anxiety that are effective in adults have small success rates in paediatric populations. 1 Theref...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news